Suzhou Dawnrays Pharmaceutical Co., Ltd.

Dawnrays is a Hong Kong-based pharmaceutical enterprise, established in 1995 with the main operations in China. Since July 2003, Dawnrays Pharmaceutical (Holdings) Ltd has been listed on the Main Board of Hong Kong Stock Exchange Market. Stock code is HK2348.

The group is engaged in the development, manufacturing and marketing of cephalosporin antibiotics, and various specialty drugs (generic drugs). The turnover was 230 million USD in 2010. The product range also covers various pharmaceutical formulations, including bulk drugs, powder for injection, tablets, capsules, granules and...